• Indian Indices
  • Global Indices
  • Commodities
  • Currency
Sensex
  • Sensex
  • Nifty
{{x.close_price| number:2}} {{x.netchg| number:2}} ({{x.perchg | number:2}}%)
Open - {{x.open | number:2}}
Prev Close - {{x.prevclose|number:2}}
Today's High - {{x.high|number:2}}
Today's Low - {{x.low|number:2}}
Advances/Declines (30 Companies)
  • 1D
  • 1W
  • 1M
  • 1Yr
  • 5Yr
{{x.upd_time}}
FTSE 100
  • FTSE 100
  • DJIA
  • NIKKEI 225
  • HANG SENG
{{x.Date}}
{{x.close| number:2}} {{x.Chg | number:2}} ({{x.PChg | number:2}}%)
Open - {{x.close | number:2}}
Prev Close - {{x.PrevClose|number:2}}
Gold
  • Gold
  • Silver
  • Crude Oil
  • Copper
{{x.Trd_Date}} ( {{x.Time}} )
{{x.ClosePrice| number:2}} {{x.change| number:2}} ({{x.perchange | number:2}}%)
Exchange - MCX
Open - {{x.Open|number:2}}
Exp Date - {{x.Exp_Date}}
Today's High - {{x.High|number:2}}
Prev. Close - {{x.PrevClose|number:2}}
Today's Low - {{x.Low|number:2}}
USDINR
  • USDINR
  • GBPINR
  • EURINR
  • JPYINR
{{x.Lasttrdtime}} ( {{x.Time}} )
{{x.ltp| number:2}} {{x.PriceDiff| number:2}} ({{x.PerChange | number:2}}%)
Exchange - NSE
Open - {{x.Open|number:2}}
Exp Date - {{x.Expirydate}}
Today's High - {{x.High|number:2}}
Prev. Close - {{x.PrevPrice|number:2}}
Today's Low - {{x.Low|number:2}}
As On 04-Jul-2022 EOD, Market Closed
SENSEX
53,234.77
326.84 (0.62%)
NIFTY
15,835.35
83.30 (0.53%)
    No Companies Visited

Back to news list
  • Lincoln Pharma tumbles after weak Q4 performance

    Lincoln Pharmaceuticals slumped 10.28% to Rs 276.35 after the company reported 12% fall in consolidated net profit to Rs 11.02 crore despite a 29% increase in revenue from operations to Rs 102.58 crore in Q4 FY22 over Q4 FY21.



    As compared with Q3 FY22, the company's net profit and revenue have declined by 37% and 14%, respectively.

    Total expenses increased by 31% to Rs 87.70 crore in Q4 FY22 over Q4 FY21.

    Profit before tax in Q4 FY22 stood at Rs 16.77 crore, up by 10% from Rs 15.31 crore in Q4 FY21.

    The company's consolidated net profit increased by 11% to Rs 69.35 crore on a 11% rise in revenue from operations to Rs 472.12 crore in Q4 FY22 over Q4 FY21.

    The company has recommended a dividend of Rs 1.50 per share for the FY 2021-22. Mahendra Patel, managing director, Lincoln Pharmaceuticals, said, "Company's expansion plans for Cephalosporin products and foray in EU and Australian markets are also progressing well."

    Lincoln Pharmaceuticals hasdeveloped 600 plus formulations in 15 therapeutic areas and has a strong product/brand portfolio lnantl-Infectlve, respiratory system, gynaecology, cardio & CNS, anti-bacterial, anti-diabetic, anti-malaria among others. The company has its strong presence in domestic market with good strength of own field force and also exports to more than 60 countries.

    Back to news list
Previous Stories :
More
Hot Pursuit News

Quick Links

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

The power of the database is harnessed by our fired-up reporters to generate interesting ideas. The reader-friendly presentation of the idea, supplemented by relevant data and information, can be accessed online through Capita Telefolio and Telefolio Gold. These ideas are used by individual investors as well as institutional investors to do further research and stay ahead.

Capital Market Publishers India Pvt. Ltd.

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071.
91-22-25229720
9769005430
Kindly note www.capitalmarket.com does not send any mobile SMS, whatsapp or twitter messages
giving any kind of stock recommendations.
For Capital Market Magazine queries mail to : subscription@capitalmarket.com
For Capital Market Online Products related queries mail to : financeshop@capitalmarket.com
For any other Capital Market Website related Queries mail to : info@capitalmarket.com
To advertise on Capital Market Websites & Capital Market Fortnightly magazine mail to : advt@capitalmarket.com
Flash News 05-Jul-2022
  •  ( 08:28) Asian stocks trading higher  
Show News
04 July 2022 00:00
2790.75
(0.64 %)
654.45
(1.44 %)
5629.85
(0.27 %)
11381.75
(0.49 %)
681.90
(1.26 %)
4365.70
(-0.43 %)
2215.50
(0.22 %)
984.55
(0.84 %)
1355.40
(0.13 %)
2374.80
(4.03 %)
719.85
(2.25 %)
832.10
(3.05 %)
1487.75
(0.66 %)
291.80
(2.62 %)
1671.15
(0.07 %)
1582.25
(0.81 %)
1091.10
(-1.56 %)
8440.25
(0.52 %)
17973.40
(1.04 %)
141.40
(0.60 %)
210.65
(2.01 %)
2413.95
(0.21 %)
473.45
(1.40 %)
828.70
(0.24 %)
854.55
(-2.15 %)
3234.65
(-2.46 %)
1000.35
(-1.01 %)
1962.35
(0.84 %)
5704.75
(0.20 %)
420.45
(-0.32 %)
Sensex 5min and Nifty 15min delayed as on .
Show Ticker
Rotate your device

Rotate your device

For the best experience please go back to portrait mode.